Myasthenia gravis during interferon alfa therapy

Amelia Evoli; Serenella Servidei; Anna Paola Batocchi; Mt Palmisani; F Apollo; Pietro Attilio Tonali

Myasthenia gravis during interferon alfa therapy

Amelia Evoli, Serenella Servidei, Anna Paola Batocchi, Mt Palmisani, F Apollo, Pietro Attilio Tonali

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.

Lingua originale	English
pagine (da-a)	382-383
Numero di pagine	2
Rivista	Neurology
Volume	45
Stato di pubblicazione	Pubblicato - 1995

Keywords

Interferon-alpha
Muscle Fibers, Skeletal
Myasthenia Gravis
Succinate Dehydrogenase

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'Myasthenia gravis during interferon alfa therapy'. Insieme formano una fingerprint unica.

Cita questo

@article{37dc940f96bd4f71bd7433eef97ca2da,

title = "Myasthenia gravis during interferon alfa therapy",

abstract = "Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.",

keywords = "Interferon-alpha, Muscle Fibers, Skeletal, Myasthenia Gravis, Succinate Dehydrogenase, Interferon-alpha, Muscle Fibers, Skeletal, Myasthenia Gravis, Succinate Dehydrogenase",

author = "Amelia Evoli and Serenella Servidei and Batocchi, {Anna Paola} and Mt Palmisani and F Apollo and Tonali, {Pietro Attilio}",

year = "1995",

language = "English",

volume = "45",

pages = "382--383",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320",

}

TY - JOUR

T1 - Myasthenia gravis during interferon alfa therapy

AU - Evoli, Amelia

AU - Servidei, Serenella

AU - Batocchi, Anna Paola

AU - Palmisani, Mt

AU - Apollo, F

AU - Tonali, Pietro Attilio

PY - 1995

Y1 - 1995

N2 - Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.

AB - Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.

KW - Interferon-alpha

KW - Muscle Fibers, Skeletal

KW - Myasthenia Gravis

KW - Succinate Dehydrogenase

KW - Interferon-alpha

KW - Muscle Fibers, Skeletal

KW - Myasthenia Gravis

KW - Succinate Dehydrogenase

UR - http://hdl.handle.net/10807/19016

M3 - Article

VL - 45

SP - 382

EP - 383

JO - Neurology

JF - Neurology

SN - 0028-3878

ER -